Carlos de Torre Minguela

Dr. Carlos de Torre Minguela

Cátedra PROSUR de Biotecnología de Alimentos, Universidad de Murcia, Murcia, Spain
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2019 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
ATAna Tapia-Abellán
Ana Tapia-Abellán
DBDiego Angosto Bazarra
Diego Angosto Bazarra
HMHelios Martínez
Helios Martínez
CMCarlos de Torre Minguela
Carlos de Torre Minguela
José Pedro Cerón-CarrascoJosé Pedro Cerón-Carrasco
José Pedro Cerón-Carrasco
PPPablo Pelegrín
Pablo Pelegrín

27 January 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
CMCarlos de Torre Minguela
Carlos de Torre Minguela
PCPablo Mesa del Castillo
Pablo Mesa del Castillo
PPPablo Pelegrín
Pablo Pelegrín
Inflammasomes are multiprotein complexes that critically control different aspects of innate and adaptive immunity. Among them we could highlight the release of pro-inflammatory cytokines that induces and maintains the inflammatory response. Usually, inflammasomes results from oligomerization of a nucleotide-binding domain-like receptor (NLR) after sensing different pathogenic or endogenous sterile dangerous signals; however other proteins as AIM2, RIG-I or Pyrin could also form inflammasome platforms. Inflammasome oligomerization leads to caspase-1 activation and the processing and release of the pro-inflammatory cytokines interleukin (IL)-1 and IL-18. Mutations in different inflammasomes are causative for multiple periodic hereditary syndromes or autoinflammatory diseases, characterized by acute systemic inflammatory flares not associated to infections, tumors or autoimmunity. This review focus on germline mutations that have been described in cryopyrin-associated periodic syndrome (CAPS) for NLRP3 or in familial Mediterranean fever (FMF) and Pyrin associated autoinflammation with neutrophilic dermatosis (PAAND) for MEFV. Besides the implication of inflammasomes in autoinflammatory syndromes, these molecular platforms are involved in the pathophysiology of different illnesses, including chronic inflammatory diseases, degenerative processes, fibrosis or metabolic diseases. Therefore, drug development targeting inflammasome activation is a promising field in expansion.

20 June 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
JMJuan Jose Martinez-Garcia
Juan Jose Martinez-Garcia
HMHelios Martínez
Helios Martínez
DBDiego Angosto Bazarra
Diego Angosto Bazarra
CMCarlos de Torre Minguela
Carlos de Torre Minguela
ABALBERTO BAROJA-MAZO
ALBERTO BAROJA-MAZO
PPPablo Pelegrín
Pablo Pelegrín
Sepsis is characterized by a systemic inflammatory response followed by immunosuppression of the host. Metabolic defects and mitochondrial failure are common in immunocompromised patients with sepsis. The NLRP3 inflammasome is important for establishing an inflammatory response after activation by the purinergic P2X7 receptor. Here, we study a cohort of individuals with intra-abdominal origin sepsis and show that patient monocytes have impaired NLRP3 activation by the P2X7 receptor. Furthermore, most sepsis-related deaths are among patients whose NLRP3 activation is profoundly altered. In monocytes from sepsis patients, the P2X7 receptor is associated with mitochondrial dysfunction. Furthermore, activation of the P2X7 receptor results in mitochondrial damage, which in turn inhibits NLRP3 activation by HIF-1α. We show that mortality increases in a mouse model of sepsis when the P2X7 receptor is activated in vivo. These data reveal a molecular mechanism initiated by the P2X7 receptor that contributes to NLRP3 impairment during infection.

7 July 2021 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
CMCarlos de Torre Minguela
Carlos de Torre Minguela
AGAna I. Gómez
Ana I. Gómez
ICIsabelle Couillin
Isabelle Couillin
PPPablo Pelegrín
Pablo Pelegrín
Pyroptosis and intrinsic apoptosis are two forms of regulated cell death driven by active caspases where plasma membrane permeabilization is induced by gasdermin pores. Caspase‐1 induces gasdermin D pore formation during pyroptosis, whereas caspase‐3 promotes gasdermin E pore formation during apoptosis. These two types of cell death are accompanied by mitochondrial outer membrane permeabilization due to BAK/BAX pore formation in the external membrane of mitochondria, and to some extent, this complex also affects the inner mitochondrial membrane facilitating mitochondrial DNA relocalization from the matrix to the cytosol. However, the detailed mechanism responsible for this process has not been investigated. Herein, we reported that gasdermin processing is required to induce mitochondrial DNA release from cells during pyroptosis and apoptosis. Gasdermin targeted at the plasma membrane promotes a fast mitochondrial collapse along with the initial accumulation of mitochondrial DNA in the cytosol and then facilitates the DNA's release from the cell when the plasma membrane ruptures. These findings demonstrate that gasdermin action has a critical effect on the plasma membrane and facilitates the release of mitochondrial DNA as a damage‐associated molecular pattern.

13 September 2011 in Science Signaling
Verified
Journal Article
Closed access
PDF file
PAPedro Andreu-Pérez
Pedro Andreu-Pérez
RERosaura Esteve-Puig
Rosaura Esteve-Puig
CMCarlos de Torre Minguela
Carlos de Torre Minguela
MLMarta López-Fauqued
Marta López-Fauqued
JBJoan Josep Bech-Serra
Joan Josep Bech-Serra
JRJuan A. Recio
Juan A. Recio
Arginine methylation of RAF proteins limits ERK activation after growth factor stimulation, thereby determining the biological response.

3 March 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CMCarlos de Torre Minguela
Carlos de Torre Minguela
MBMaria Barberà-Cremades
Maria Barberà-Cremades
AGAna I. Gómez
Ana I. Gómez
FMFátima Martín-Sánchez
Fátima Martín-Sánchez
PPPablo Pelegrín
Pablo Pelegrín
The activation of P2X7 receptor (P2X7R) on M1 polarized macrophages induces the assembly of the NLRP3 inflammasome leading to the release of pro-inflammatory cytokines and the establishment of the inflammatory response. However, P2X7R signaling to the NLRP3 inflammasome is uncoupled on M2 macrophages without changes on receptor activation. In this study, we analyzed P2X7R secretome in wild-type and P2X7R-deficient macrophages polarized either to M1 or M2 and proved that proteins released after P2X7R stimulation goes beyond caspase-1 secretome. The characterization of P2X7R-secretome reveals a new function of this receptor through a fine-tuning of protein release. We found that P2X7R stimulation in macrophages is able to release potent anti-inflammatory proteins, such as Annexin A1, independently of their polarization state suggesting for first time a potential role for P2X7R during resolution of the inflammation and not linked to the release of pro-inflammatory cytokines. These results are of prime importance for the development of therapeutics targeting P2X7R.